Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice.
D000818:Animals; D001679:Biogenic Amines / Q000032:analysis; D001921:Brain / Q000187:drug effects*; D001923:Brain Chemistry; D004298:Dopamine / Q000032:analysis*; D018492:Dopamine Antagonists; D004338:Drug Combinations; D004347:Drug Interactions; D004597:Electroshock; D004952:Esters / Q000494:pharmacology; D005260:Female; D010134:Fenclonine / Q000494:pharmacology; D008781:Methyltyrosines / Q000494:pharmacology; D051379:Mice; D008815:Mice, Inbred Strains; D009638:Norepinephrine / Q000032:analysis* / Q000037:antagonists & inhibitors; D012110:Reserpine / Q000494:pharmacology*; D012640:Seizures; D012701:Serotonin / Q000032:analysis*; D012702:Serotonin Antagonists; D013747:Tetrabenazine / Q000494:pharmacology; D013997:Time Factors
D001679:Biogenic Amines; D018492:Dopamine Antagonists; D004338:Drug Combinations; D004952:Esters; D008781:Methyltyrosines; D012702:Serotonin Antagonists; D012701:Serotonin; D012110:Reserpine; D010134:Fenclonine; D004298:Dopamine; D009638:Norepinephrine; D013747:Tetrabenazine